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Abstract
Background: Genomic biobanking research is undergoing exponential growth in Africa raising a host of legal,
ethical and social issues. Given the scientific complexity associated with genomics, there is a growing recognition
globally of the importance of science translation and community engagement (CE) for this type of research, as it
creates the potential to build relationships, increase trust, improve consent processes and empower local
communities. Despite this level of recognition, there is a lack of empirical evidence of the practise and processes
for effective CE in genomic biobanking in Africa.
Methods: To begin to address this vacuum, 17 in-depth face to face interviews were conducted with South African
experts in genomic biobanking research and CE to provide insight into the process, benefits and challenges of CE
in South Africa. Emerging themes were analysed using a contextualised thematic approach.
Results: Several themes emerged concerning the conduct of CE in genomic biobanking research in Africa.
Although the literature tends to focus on the local community in CE, respondents in this study described three
different layers of stakeholder engagement: community level, peer level and high level. Community level
engagement includes potential participants, community advisory boards (CAB) and field workers; peer level
engagement includes researchers, biobankers and scientists, while high level engagement includes government
officials, funders and policy makers. Although education of each stakeholder layer is important, education of the
community layer can be most challenging, due to the complexity of the research and educational levels of
stakeholders in this layer.
Conclusion: CE is time-consuming and often requires an interdisciplinary research team approach. However careful
planning of the engagement strategy, including an understanding of the differing layers of stakeholder
engagement, and the specific educational needs at each layer, can help in the development of a relationship based
on trust between the research team and various stakeholder groups. Since the community layer often comprises
vulnerable populations in low and middle income countries (LMICs), co-development of innovative educational
tools on genomic biobanking is essential. CE is clearly a component of a broader process best described as
stakeholder engagement.
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Background
Genomic biobanking and associated research create unique
scientific and ethical challenges globally. Research in gen-
omics is undergoing exponential growth in Africa as a re-
sult of international collaborative projects such as HapMap,
MalariaGEN, H3Africa, B3Africa and other local collabora-
tions. While South Africa does not have population based
biobanks currently, there are several disease specific speci-
men collections in the country. Scientists in South Africa
have become a part of these international initiatives, and
have complemented efforts by the Department of Health
and the National Health Laboratory Service to develop and
promote genomic biobanking in the region [1]. Although
welcomed, the research raises a host of legal, ethical and so-
cial issues for the continent, including challenges with the
traditional understanding of consent information, questions
of benefit-sharing, ownership, fears of exploitation, dis-
crimination and stigmatisation [2, 3]. These add to the
well-documented challenges associated with conducting
research in vulnerable populations in LMICs [4, 5]. Many
of the difficulties genomic and biobanking researchers in
South Africa face have been experienced in other High
Income Countries (HIC), but genomic and biobanking re-
search present particular ethical challenges in South
Africa. The country’s history of exploitation has impacted
negatively on trust in medical research [6] and attempts at
data and sample mining persist [7]. Empirical studies have
suggested that biological samples have a cultural signifi-
cance that must be respected and can affect the use and
reuse of samples [6]. Furthermore, the complexity of gen-
omic biobanking research coupled with low literacy rates
in many communities, and the lack of vocabulary for
many terms in indigenous African languages can also
challenge understanding during consent processes [8].
Research on Human Immunodeficiency Virus (HIV) in-
fections and genetics and genomics raise similar ethical
challenges. Both disease entities share the phenomenon of
scientific complexity, transmissibility and the potential for
stigmatisation for different reasons. It is therefore unsur-
prising that HIV research in Africa has similarly raised
considerable ethical and social issues over the past three
decades, and CE has been demonstrated as a key way to
address some of these issues [9–12]. CE in health research
typically refers to the efforts of researchers “to develop
partnerships with local stakeholders and to involve them
in assessing local health problems, determining the value
of research, planning, conducting and overseeing research,
and integrating research into the health care system” [13].
It assumes that interventions that are community based
and involve all major stakeholders are often more
effective, sustainable, and more likely to reflect the health
needs of the communities while promoting capacity devel-
opment [14]. There has been a growing body of literature
on the importance CE for the ethical conduct of research
[2, 11, 15, 16]. Although the goals will vary according to
the research and its setting, building relationships, in-
creasing trust, improving the informed consent process
and empowering local communities is critical to the suc-
cess of all research projects [12, 17, 18]. Essential to this
process is an understanding of the research [19].
Despite the perceived importance of CE in promoting
the ethical conduct of research, challenges in its imple-
mentation and establishing its impact remain. Defining
‘community’ is challenging and can depend on the par-
ticular social, cultural and geographical context in which
the research takes place. The conception of CE can simi-
larly vary and community involvement, consultation,
participation or partnership have all been considered to
be CE [2]. Questions also persist as to what constitutes
meaningful engagement [20]. The difficulty in defining
CE additionally makes the effective evaluation of CE
challenging. These challenges are particularly pertinent
as there is a lack of guidance as well as empirical evi-
dence of the practise and processes for effective CE in
genomic biobanking in Africa. A 2015 review by Tin-
dana et al. revealed that out of the 38 published articles
on CE in sub-Saharan Africa, 34 related to biomedical
research with only 4 specific to genetic and genomic re-
search in Africa. The H3Africa Community Engagement
Guidelines remain the only CE guidelines for genomic
biobanking research that is specific to the African con-
tinent [21].
Within South Africa, previous studies have explored re-
search participant perceptions around the use of biological
samples in research [3], the views of researchers regarding
perceived ethical issues in genomic biobanking [6] and ex-
periences with a researcher-driven, population-specific
CAB [18]. CE was identified as an important contributor
to building trust in genomic biobanking research [6], but
there has been a paucity of empirical work in CE and gen-
omic biobanking research in South Africa. We therefore
conducted interviews with experts in CE as well as key
stakeholders in genomic biobanking research in South
Africa, to explore some of the pertinent issues concerning
CE in the country. This paper reports on these findings
and is the first study to focus exclusively on CE in gen-
omic biobanking research in South Africa. This research
will guide future phases of work involving empirical inves-
tigation into similar issues with patients and community
advisory board members (CAB). The findings of this work
will inform the development of a CE strategy for a bio-
bank in Cape Town, and may inform the development of
similar guidelines for urban biobanks across Africa.
Methods
This was a qualitative research project involving face to face
in-depth interviews with expert stakeholders. Using purpos-
ive sampling, we selected respondents with expertise in
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genomics and biobanking research and/or CE to provide
insight into the process, benefits and challenges of CE in
South Africa (see Table 1). Within these parameters, the re-
search team used their collective experience and network
to identify respondents. Respondents were identified
through some of the research teams’ (CS, PT, KM) mem-
bership of various H3Africa Working Groups and the
experience and involvement of the research team with CE
for research in sub-Saharan Africa (PT). We also drew on
the teams’ experience (CS, MH, KM) and network devel-
oped with researchers in South Africa who were not part of
the H3Africa Consortium, but had experience in CE and/or
genomic biobanking research in South Africa. Respondents
were confined to those who resided in the Western Cape,
or who were available to take part in an interview in Cape
Town between March and June 2016. Respondents
included medical scientists, biobank staff and CE practi-
tioners. Although all respondents were based in South
Africa, many are involved in multisite projects with collabo-
rators across the continent, thus some of the results may
have implications for CE throughout Africa.
The 17 in-depth interviews took place in Cape Town
and lasted approximately 50 min each. After outlining the
project and the purpose for the interview, written in-
formed consent for participation and recording of the
interview was obtained. Interviews explored participants’
experience with CE in the context of genomics biobanking
research. Questions focused on respondents’ perspectives
on the goals and purpose of CE, how CE should be struc-
tured as well as challenges with CE generally. Respondents
who had experience with genomic biobanking re-
search were asked to reflect on these issues in the
context of that research. As part of this project,
interviews with 10 CAB members and 30 research
participants were ongoing at the time of submitting
this paper. These 40 interviews were conducted in-
dependently of the interviews reported in this paper,
and are examining CAB and research participants
experiences and perspectives of CE in South Africa.
The findings of those interviews will be published at
a later date and will be compared with the findings
in this paper.
All interviews were conducted in English, recorded and
transcribed verbatim. A codebook was developed by the
interviewer (CS) and discussed with two team members
(PT, MH). Emerging themes were discussed with the prin-
cipal investigator (KM) and the team (CS, PT, MH). Data
analysis was facilitated by using the software Nvivo. A
contextualised thematic approach was used to interpret
the results. This study was approved by the Research
Ethics Committees at Stellenbosch University N14/02/010
and the University of Cape Town 084/2016.
Results
All respondents noted the importance of CE gener-
ally, its importance in research, and that CE should
be included as an integral part of the research
process for the ethical conduct of research. Trust, CE
as a means to empowerment, reciprocity and feedback
to a community, and the importance of evaluating CE
were all highlighted as being of significance. In
discussing these elements, respondents touched on
the value of these issues as they relate to genomic
biobanking research. In particular, trust was identified
as being significant in this context, as key concepts of
the research itself and other issues, such as broad
consent, may not be understood.
I don’t think that our community fully understands
the whole issue of what broad consent is…but I think
usually the scenarios that work is an element of trust.
I will get a 90% hit for a sample for bio banking
because of the nature in which I have engaged with
people. (Researcher, 01)
For the purposes of this paper, we present the key
themes that emerged from the interviews as they specif-
ically relate to genomic biobanking research in South
Africa.
Layers of engagement
Although the questions sought to explore CE, respon-
dents discussed the different layers of engagement that
may be necessary prior to, during and after the research.
They reflected upon the differing layers, the type of
engagement that is necessary and the justification for
engagement with each layer.
Although engagement with ‘the community’ was most
discussed, the three different layers of engagement de-
scribed by respondent were:
 High level: policy makers, institutions and funders
 Peer level: scientists, medical doctors, biobankers,
nurses and field workers
 Community level: community members, patients,
research participants, support groups, field workers
and CABs
Table 1 Breakdown of respondents
Researchers (Genomic and biobank researchers) 10
CE experts 3
Lawyer 1
Study nurse 1
Genetic counsellor 1
Genetic counsellor & member of patient advocacy group 1
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These differing layers were explicitly described by
one respondent who had considerable international
experience in multi-site projects, but were echoed by
other respondents as well. The attention given to
each layer varied amongst respondents. Researchers
discussed all layers, but gave most attention to the
community level and high level, while CE experts
tended to focus on the peer and community level of
engagement.
So there are three levels of CE. There's high level,
there's peer level and then there’s community and
public. (Researcher, 04)
High level engagement
High level engagement was considered to include
those stakeholders who are involved in decision mak-
ing on an institutional, national or international level.
This could include government officials, policy
makers, funders or a hospital director/superintendent.
In discussing the manner and purpose of engagement,
it was felt that this will vary according within each
level, and this layer could perhaps be subdivided be-
tween those who are developing policy and financially
supporting the research, and those whose approval or
permission is necessary prior to the commencement
of the research.
For policy makers and funders, high level engage-
ment may be necessary to change policy, motivate for
increased funding or obtain the necessary approvals
and permissions for the research. There was recogni-
tion that genomic biobanking research is expensive
and it may take time before there is a clinical applica-
tion from the research. However, considerable finan-
cial investment is required to ensure its sustainability,
and economic arguments demonstrating the benefits
of genomic biobanking research may be needed for
these discussions.
And of course the political leaders are critical, because
every single thing you do at the end you need to have
it implemented, especially if you are doing health
research. (Researcher, 10)
High level policy makers have very short attention
spans and you need to wrap their focus and drive
home your messaging in minutes. If you don’t create
an economic argument they are not interested so just
to try to convince them that they need to spend money
on R and D is not going to fly. You need to explain to
them why or what the benefits are in terms of loss of
revenue or overspending because of lack of a proper
strategic plan. (Researcher, 04)
Peer level engagement
At some level, all respondents discussed the need for
peer engagement. The concept of a peer generally re-
ferred to someone with a medical background who
would be involved in the research in some way. Once
again, there was a split within this layer, between those
leading the research and those who directly engaged
with the patients.
In reflecting upon peer engagement, respondents con-
sidered that it may be necessary for two purposes: to de-
velop collaborations for research and to educate. The
purpose of education can be twofold. First, respondents
spoke about the importance of demonstrating to scien-
tists in particular, the importance and need for CE and
the benefit of a better informed community. Respondents
noted that effective monitoring and evaluation of CE can
help justify CE, as this will provide evidence of its effect-
iveness. They also need to be engaged and educated about
how to conduct CE. The development of these collabora-
tions could occur at scientific meetings and conferences
where CE could be included as part of the programme.
Most respondents emphasised the importance of en-
gaging and educating frontline staff such as researchers,
recruiters and field workers who will be interacting with
participants. They recommended that doctors and other
medical professionals need to be made aware of the
importance of genomic biobanking research so that they
are willing to refer patients. Although frontline staff may
have a medical background, their knowledge about
genomics and biobanking research cannot be assumed.
In particular, respondents opined that field workers may
require in-depth training to ensure that they are all con-
veying the same message.
And then we also need to support the efforts of the
individual researchers, because a lot of them may not
have the resources or the expertise or the interest to do
effective CE. (Researcher, 04)
We assume that the staff knows what they are
doing, even some of the nurses that are recruiting
people in the genomic biobanking projects or in
biomedical research or genomic research, we assume
that the nurses understand the genomics. But no
one has taught them, so why should we assume?
(Researcher, 08)
Community level engagement
Identification of the community layer was less expli-
cit, and difficulty in defining the community was
discussed. This is partly due to the difficulty in defin-
ing this group, but it is also dependent on whether it
is a population based study or disease specific. It did,
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however, extend to including patients, members of
support groups, a community advisory board (CAB),
field workers, patients with a specific genetic condi-
tion and the general public. For some, field workers
could also occupy this layer as they may be drawn
from the community they are working in, but it was
acknowledged that they may have a conflicted role as
both members of the community and part of the re-
search team. The purpose of engagement with this
layer is to educate and build trust, but similar to the
high level layer, the length of time it can take to
achieve results, was perceived to be challenging.
It would depend a lot on the type of research that
you want to do. If it is research that involves
families it’s very, very different. My engagement
would be much more different than research that
engages individual people…If you have to do
monogenic research for gene hunting that means
you will have to deal with family. Your engagement
will be almost on a family basis and individual
family approach (Researcher, 10)
I think that if you speak to the recruiters that they’ll
say it’s a very conflicted role because on the one hand
they are X people who are members of this target
community. And so, they are gate keepers and they
also feel a sense of advocacy for the rights of the
participants. (CE expert, 02)
Education of stakeholders in the community layer
The importance of educating each layer was dis-
cussed, but the purpose of education of each layer
differed. By far the most attention was devoted to
education of the community layer. The importance
in educating this layer was deemed to be critical but
there was the feeling that educating about genomic
biobanking research is particularly challenging and
that considerable time to explain genomic concepts
to the patient is necessary. Challenges related to the
complexity of the topic, the difficulty in making the
information accessible, and the low education levels
of many who are likely to be part of this research in
South Africa. However, respondents commented that
while there are difficulties with educating the com-
munity about genomics and biobanking, it is not im-
possible and efforts should be made to make the
information accessible.
So access to that knowledge is difficult but it doesn't
mean that it is impossible. It just means that we need
to find a way to make it accessible to the people.
(Researcher, 10)
Education was also perceived to be crucial to alleviate
concerns of the community about the research and de-
stigmatise feelings of blame about their children inherit-
ing any genetic disorders.
It's about self and it's about the future. It is also
about going back and it's about guilt and blame,
about where it comes from and why me? And so we
have to go back to be able to go forward and often
we get a stumbling block going back, because then
there is blame. And so we have to reinforce that
and you know go through the process that your
parents didn't know that they were…carrying this
condition (Researcher, 09)
Education was also deemed essential to address con-
cerns about exploitation and to prevent exploitation.
Informing the community about the African ownership
of the research and that the samples will remain in
Africa was considered essential to allay fears of exploit-
ation. Respondents did touch on concerns about the
over-research of participants in Cape Town and the
South African public health sector generally. One re-
spondent raised particular concerns about the attempt
of the health insurer, Discovery Health, to obtain sam-
ples from patients in return for reduced cost genetic
testing as patients may not understand the implications
of this test.
You would be surprised at what community members
bring to the table when it comes to research…as you
might know some of the research that has been done
where samples have had to be sent away… But a
biobank that is based in Africa that has stakeholders
from Africa and who decides over issues that happen
in Africa is different. (CE expert, 03)
Genetic information is very sensitive. It's very powerful.
I mean it can be used to discriminate against you
[Discovery] are making it available to the general
public and they don't know a lot about genetics and
what it actually entails. (Genetic counsellor, 01)
Finally, the significance of educational tools in over-
coming this difficulty was highlighted. Such educational
tools were necessary at all layers of engagement, not
only the community level. There was the sense that add-
itional tools were needed to begin to unpack this com-
plex subject matter. Social media, newsletters, posters,
pamphlets, videos, science exhibitions, workshops/online
courses and generic or disease specific awareness days
were all mentioned as possible educational tools. These
tools, in addition to verbal discussions, were felt to be
important as information delivered orally should be
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backed up with some other intervention. Attention was
also given to the words and metaphors that can help
stakeholders in the community layer better understand
the research. Examples provided included soap operas to
explain paternity, cookies and recipes to explain genet-
ics, and toy soldiers to explain HIV.
Respecting cultural norms and practices
For the peer group, respondents noted that education is
essential so that peers respect cultural norms and prac-
tices common in some South African communities.
Failure to do so may result in delays to the research. For
example, access may only be obtained through the chief
or elders in more rural settings and there may be a
process to follow before informed consent can be ob-
tained. It was noted that many of the communities that
researchers work within are patriarchal and the consent
of a husband or father may be necessary prior to the
consent of a woman. Similarly community consent or
support or discussions with family may be necessary
prior to individual consent. In such settings this trad-
ition must be respected and followed.
Like I know for our Xhosa patients for instance…they
need to go to the community leaders or to their
elders…if you're trying to get someone's consent for
something like this they might say to you “Well, I'm
not the decision maker” so that could also be a
problem and I think that you should think about this
when you do the recruitment process. (Genetic
Counsellor, 01)
Turning specifically to genomic biobanking research,
the cultural significance of the samples and understand-
ing the cultural narrative around disease in many South
African communities were particularly emphasised.
In discussing the samples, respondents noted the cul-
tural beliefs and concerns on the withdrawal of blood,
the taking of samples and the storage of hair. Many
South African traditional communities believe that they
will linger in this life if their sample remains in a fridge
but there are also fears held that their blood will be used
for “muti” or witchcraft. They also believe that donating
samples may be offensive to their ancestors in some
way. These beliefs must be understood and respected.
They contacted the family back in the rural area who
agreed they’ll come and they will give samples; and
then they [the researchers] never really travelled there
to get them. And they were told “No way, you know
one of the elders has pointed out that this is totally
disrespectful to the ancestors and we don’t want to
give samples for this.” And they didn’t, they wouldn’t.
(Researcher, 07)
Then you sit with…different traditions. Some people
believe, especially in the various cultures that you
know if a piece of the body is a sample in the fridge…
they can’t move on. (Researcher, 03)
Respondents noted that perceptions of disease and ill-
ness in some communities may differ from a biomedical
understanding. In explanations of disease, the team must
be sensitive to the cultural understanding of the disease;
both the biomedical and cultural explanations must be
respected.
Similarly explanations of inheritance of disease may be
considered disrespectful to the ancestors. One respond-
ent reported that a family refused to give samples as the
elders believed it to be disrespectful to the ancestors.
For others, they may struggle to accept certain explana-
tions due to their belief in God and there may be a cer-
tain discomfort around discussions about sex and
sexuality. Researchers must be prepared for these con-
cerns and queries and be in a position to address them.
And then we engage in conversations about how the
genetic story intersects with their own narrative and I
think it’s been a win/win because that way people get
to question and ask questions about what the genetics
is and what their own oral history is about.
(Researcher, 01)
Also respecting how a particular community or
members within the community will explain and
understand illness and health seeking behaviour
around that explanation. And how that aligns with
maybe how the project is talking about that particular
illness and respecting both those different explanations
(CE expert, 02)
Discussion
CE in any context is challenging, and the development
and implementation of a CE strategy requires time,
patience and resources as well as considerable interper-
sonal skills and flexibility [11]. South Africa has consid-
erable experience in CE for HIV research, and the
lessons learned in that context should be drawn upon
for genomic biobanking research. However, the com-
plexity of genomic biobanking research, the capacity of
those involved in engagement, and the cultural and soci-
etal concerns that are drawn out by the research, pose
additional challenges to CE.
CE is recognised as intrinsically respecting and
protecting communities, but engagement for this
research must go beyond the community layer, as
engagement of each stakeholder layer is important to
ensure the success of genomic biobanking research
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in Africa. Most published work on CE for genomic
biobanking research often tends to emphasise CE at
the level of the target community or population
hosting the project [18], but our research has
highlighted the need to take other layers of engage-
ment seriously, such as peer engagement with other
scientists and high level engagement with policy
makers which can influence the uptake of best prac-
tices. Fundamental to CE is recognition of its im-
portance in the ethical conduct of research. This
must be understood and recognised by those in the
peer and high level layer to ensure that adequate
resources are dedicated to CE. Engagement with
these layers can ensure that CE becomes an integral
part of good governance for genomic biobanking re-
search. Thus our focus in genomic research in South
Africa must go beyond CE to encompass stakeholder
engagement.
Increasingly, there is recognition of the importance of
stakeholder engagement in HICs in the field of genomic
biobanking research [21–24]. It has been referred to as
“the process of meaningful involvement of those who
are engaged in making decisions about programs” [21].
For each layer to be involved, there must be an under-
standing of the research and education of the different
stakeholder groups is therefore essential. To an extent,
the H3Africa Consortium is already engaged in this
process, but gaps nevertheless remain.
H3Africa Consortium meetings are generally held
twice a year with principal investigators (PIs), co-
investigators, members of the various Working Groups
as well as funders in attendance. Successes have led to
the decision to fund H3Africa for a further 5 years and
the requirement that 5% of all grants include a CE plan.
However, national funders generally are not in attend-
ance and there is no formal process for researchers to
engage with such bodies in South Africa. Sustainability
of genomic biobanking research post-H3Africa has been
raised as a concern [25], thus there is a need for gen-
omic biobanking researchers in South Africa to start this
process of engagement to ensure its continued develop-
ment and success.
Equally, the H3Africa Ethics and Regulatory Issues
Working Group has developed an Ethics and Governance
Framework for Best Practice in Genomic Research and
Biobanking in Africa. This framework was developed after
engagement with some REC members, members of the
H3Africa Consortium and regulators from specific African
countries [2]. To a certain extent, this framework can help
support individual RECs, as well as researchers in South
Africa to ensure the ethical conduct of genomic biobank-
ing research. However, broad consent can never be truly
informed as possible risks cannot be known and thus re-
mains contentious [26–28]. Gaps in the regulation of
genomic biobanking research in South Africa have been
identified [7, 29], and this framework can help address
some of these shortcomings, including informing the de-
velopment of specific guidelines on genomic biobanking
at institutional and national levels.
Similarly, the H3Africa Community Engagement Working
Group is involved in engaging with the Consortium gener-
ally, and is working on individual projects looking at the
importance of CE and providing advice in the development
of CE plans [30]. Looking beyond the Consortium, there is a
need to focus on stakeholder engagement rather than CE
only.
The three layers of engagement described by re-
spondents in this study, however, are not rigid, but
will vary according to the research context. Nurses
and other medical personnel were identified as po-
tentially engaging with and recruiting participants,
but they were seen as separate from field workers.
With the exception of one respondent who was a CE
expert, field workers were perceived by respondents
to be a part of the community layer. As they are
part of the research team, field workers may be per-
ceived differently by community members [31]. This
demonstrates that it is not possible to definitely
group individuals. Individuals can occupy different
layers depending on the particular conceptualisation
of ‘community’ [10] and, although they may be a
community member educated in the research, they
can perhaps continue to represent their community.
However questions may arise over whether the com-
munity perceives these field workers as representing
them and assumptions cannot be made about the
layer that field workers may represent. Whatever the
layer, fieldworkers have an important role in the in-
formed consent process, helping participants to con-
ceptualise the research. It is therefore essential that
they receive adequate training [18, 31, 32].
Equally, a better understanding of the role and the
layer that fieldworkers occupy will also be important
in future evaluation. If field workers are part of the
peer layer, their role will be in ensuring that the com-
munity level is engaged and understands the research.
They will have an active role in CE and bolstering
the consent process. On the other hand, field workers
occupying the community layer will have a more
active role in representing the community and voicing
any concerns associated with the research. In reality
such roles for field workers are not mutually exclusive
and perhaps cannot be delineated, but the community’s
perception of their role must be better understood.
For each layer, education is important and implicit in
this is the need for co-learning [33], particularly between
the peer and community layer. Across both layers, prob-
lems understanding genomic biobanking research persist
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and suggestions for capacity development of the peer
layer for genomic biobanking research [25] and research
generally have been discussed elsewhere [34]. Updating
undergraduate medical curricula to include modules on
genomics and biobanking is essential. Likewise the de-
velopment of educational courses for medical doctors,
REC members and scholars of law and ethics is
important.
The challenges surrounding the complexity of genomic
and biobanking research, language issues, coupled with
the cultural sensitives in some communities, was seen as
the greatest challenge to genomic and biobanking research
in Africa. Challenges in engaging communities where
there are low levels of literacy means there are often low
levels of awareness and understanding of research and this
can lead to the diagnostic misconception in the context of
genomic biobanking research [35].
There have been calls for simple and accessible language
in conjunction with visual aids to explain genomic re-
search [18] and a growing body of literature has demon-
strated the effectiveness of such tools in South Africa and
other LMICs [36, 37]. It is clear from our findings that
there are on-going efforts to simplify the language in
which information is presented as well as develop appro-
priate educational tools.
In an analysis of H3Africa consent forms, it was found
that there were broadly five strategies employed to explain
genetics and genomics that focused on heredity, heredity
and health, genes and disease causation, disease suscepti-
bility and progression and phenotype or a combination of
these strategies [38]. However, consent forms in indigen-
ous African languages were not included in that study,
and it is unclear whether the lack of vocabulary for scien-
tific terms such as “gene”, “DNA” or “biobank” in many
African languages has been addressed.
As part of our project, we developed a video on bio-
banking research and educational pamphlets that further
discuss medical research, genetic and genomic research,
and biobanks. This video has been made publicly
available on You Tube [39] as well as in the H3Africa
Consent Guideline. Both the pamphlets and the video
have been disseminated at conferences and workshops,
to researchers and REC members, and made available to
individual clinics and research participants. RECs are
disseminating the videolink and pamphlets to re-
searchers as most studies today have a separate consent
process for the collection and storage of samples for
genomics research in the future. It is essential to not
only disseminate to research participants, but also to
stakeholders in the peer layer, given that they educate
stakeholders at the community level. The recently
revised H3Africa Community engagement guidelines
provide examples of other educational tools that have
been used within the H3Africa consortium including
comic books, pictographs, theatrical engagement, and
social media to engage their target communities.
Finally, the cultural issues raised by genomic bio-
banking research, and the need to respect local narra-
tives and customs, are similar to particular challenges
with this research discussed elsewhere [3, 6]. While
attempts to develop research capacity for genomic
biobanking research are indeed to be welcomed, con-
cerns about the potential exploitative nature of this
research remain [7, 25]. Given South Africa’s history
of exploitation, this is perhaps a pertinent issue for
each layer. Equitable research collaborations is one
step to address such fears [25], but a more robust
regulatory framework can also address this issue.
Limitations
A limitation with this publication is that it focused on the
perceptions of researchers, genetic counsellors and CE ex-
perts only. Further empirical work on the views of those
who have or are likely to be involved in genomic and bio-
banking research such as research participants, fieldworkers
and research ethics committees is necessary. As part of this
project, the views of research participants and CAB mem-
bers are being elicited and the views in this paper will be
compared with the views that will emerge from research
participants and CAB interviews.
A further limitation lies in the sampling method
adopted. Respondents were generally drawn from the
peer level and quite senior. They were also researchers
who were PIs of research projects that were actively en-
gaged in CE. The views of these respondents are biased
in favour of CE and may not be reflective of all
researchers engaged with genomic and biobanking re-
search. Due to the network of the research team, the re-
spondents were mainly drawn from the H3Africa
Consortium. However, most respondents were involved
or are currently involved in research projects outside of
the H3Africa network, thus the findings are likely to be
representative of views beyond the H3Africa network.
Finally, many of the respondents drew on their experi-
ences that involved work in other African countries and
these findings may have implications for research be-
yond South Africa, however further work in differing
contexts across sub-Saharan Africa is necessary.
Conclusion
There are many challenges in CE in genomic biobanking
research in LMICs due to the complexity of scientific and
ethical concerns coupled with educationally disadvantaged
participants with low levels of scientific knowledge and
language and communication challenges. The impact of
culture, educational approaches and community empower-
ment can all have an important bearing on how to interact
with a community to begin a CE process. Engagement must
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however extend beyond stakeholders in this community
layer and encompass high level and peer engagement as
well. Many medically qualified health workers have limited
knowledge on genomics and biobanking. The study has
shown that CE is merely a component of a broader con-
cept, namely, stakeholder engagement.
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